RESUMEN
The classical pathway (CP) is a potent mechanism for initiating complement activity and is a driver of pathology in many complement-mediated diseases. The CP is initiated via activation of complement component C1, which consists of the pattern recognition molecule C1q bound to a tetrameric assembly of proteases C1r and C1s. Enzymatically active C1s provides the catalytic basis for cleavage of the downstream CP components, C4 and C2, and is therefore an attractive target for therapeutic intervention in CP-driven diseases. Although an anti-C1s mAb has been Food and Drug Administration approved, identifying small-molecule C1s inhibitors remains a priority. In this study, we describe 6-(4-phenylpiperazin-1-yl)pyridine-3-carboximidamide (A1) as a selective, competitive inhibitor of C1s. A1 was identified through a virtual screen for small molecules that interact with the C1s substrate recognition site. Subsequent functional studies revealed that A1 dose-dependently inhibits CP activation by heparin-induced immune complexes, CP-driven lysis of Ab-sensitized sheep erythrocytes, CP activation in a pathway-specific ELISA, and cleavage of C2 by C1s. Biochemical experiments demonstrated that A1 binds directly to C1s with a Kd of â¼9.8 µM and competitively inhibits its activity with an inhibition constant (Ki) of â¼5.8 µM. A 1.8-Å-resolution crystal structure revealed the physical basis for C1s inhibition by A1 and provided information on the structure-activity relationship of the A1 scaffold, which was supported by evaluating a panel of A1 analogs. Taken together, our work identifies A1 as a new class of small-molecule C1s inhibitor and lays the foundation for development of increasingly potent and selective A1 analogs for both research and therapeutic purposes.
Asunto(s)
Complemento C1s , Vía Clásica del Complemento , Animales , Ovinos , Péptido Hidrolasas , Complemento C1/metabolismo , Endopeptidasas , Piridinas/farmacologíaRESUMEN
Although high titers of neutralizing Abs in human serum are associated with protection from reinfection by SARS-CoV-2, there is considerable heterogeneity in human serum-neutralizing Abs against SARS-CoV-2 during convalescence between individuals. Standard human serum live virus neutralization assays require inactivation of serum/plasma prior to testing. In this study, we report that the SARS-CoV-2 neutralization titers of human convalescent sera were relatively consistent across all disease states except for severe COVID-19, which yielded significantly higher neutralization titers. Furthermore, we show that heat inactivation of human serum significantly lowered neutralization activity in a live virus SARS-CoV-2 neutralization assay. Heat inactivation of human convalescent serum was shown to inactivate complement proteins, and the contribution of complement in SARS-CoV-2 neutralization was often >50% of the neutralizing activity of human sera without heat inactivation and could account for neutralizing activity when standard titers were zero after heat inactivation. This effect was also observed in COVID-19 vaccinees and could be abolished in individuals who were undergoing treatment with therapeutic anti-complement Abs. Complement activity was mainly dependent on the classical pathway with little contributions from mannose-binding lectin and alternative pathways. Our study demonstrates the importance of the complement pathway in significantly increasing viral neutralization activity against SARS-CoV-2 in spike seropositive individuals.
Asunto(s)
Anticuerpos Neutralizantes , Anticuerpos Antivirales , Vacunas contra la COVID-19 , COVID-19 , Vía Clásica del Complemento , Pruebas de Neutralización , SARS-CoV-2 , Humanos , SARS-CoV-2/inmunología , Anticuerpos Neutralizantes/inmunología , Anticuerpos Neutralizantes/sangre , COVID-19/inmunología , Anticuerpos Antivirales/inmunología , Anticuerpos Antivirales/sangre , Vía Clásica del Complemento/inmunología , Vacunas contra la COVID-19/inmunología , Masculino , Femenino , Persona de Mediana Edad , Adulto , Convalecencia , Anciano , Proteínas del Sistema Complemento/inmunologíaRESUMEN
The complement system serves as the first line of defense against invading pathogens by promoting opsonophagocytosis and bacteriolysis. Antibody-dependent activation of complement occurs through the classical pathway and relies on the activity of initiating complement proteases of the C1 complex, C1r and C1s. The causative agent of Lyme disease, Borrelia burgdorferi, expresses two paralogous outer surface lipoproteins of the OspEF-related protein family, ElpB and ElpQ, that act as specific inhibitors of classical pathway activation. We have previously shown that ElpB and ElpQ bind directly to C1r and C1s with high affinity and specifically inhibit C2 and C4 cleavage by C1s. To further understand how these novel protease inhibitors function, we carried out a series of hydrogen-deuterium exchange mass spectrometry (HDX-MS) experiments using ElpQ and full-length activated C1s as a model of Elp-protease interaction. Comparison of HDX-MS profiles between unbound ElpQ and the ElpQ/C1s complex revealed a putative C1s-binding site on ElpQ. HDX-MS-guided, site-directed ElpQ mutants were generated and tested for direct binding to C1r and C1s using surface plasmon resonance. Several residues within the C-terminal region of ElpQ were identified as important for protease binding, including a single conserved tyrosine residue that was required for ElpQ- and ElpB-mediated complement inhibition. Collectively, our study identifies key molecular determinants for classical pathway protease recognition by Elp proteins. This investigation improves our understanding of the unique complement inhibitory mechanism employed by Elp proteins which serve as part of a sophisticated complement evasion system present in Lyme disease spirochetes.
Asunto(s)
Proteínas de la Membrana Bacteriana Externa , Borrelia burgdorferi , Vía Clásica del Complemento , Humanos , Proteínas de la Membrana Bacteriana Externa/química , Proteínas de la Membrana Bacteriana Externa/genética , Proteínas de la Membrana Bacteriana Externa/metabolismo , Borrelia burgdorferi/inmunología , Borrelia burgdorferi/metabolismo , Borrelia burgdorferi/genética , Complemento C1r/metabolismo , Complemento C1r/genética , Complemento C1s/metabolismo , Complemento C1s/genética , Complemento C1s/química , Vía Clásica del Complemento/inmunología , Lipoproteínas/metabolismo , Lipoproteínas/genética , Lipoproteínas/química , Lipoproteínas/inmunología , Enfermedad de Lyme/genética , Enfermedad de Lyme/inmunología , Enfermedad de Lyme/microbiología , Unión ProteicaRESUMEN
For many years complement activation in systemic lupus erythematosus (SLE) was viewed as a major cause of tissue injury. However, human and murine studies showed that complement plays a protective as well as a proinflammatory role in tissue damage. A hierarchy is apparent with early classical pathway components, particularly C1q, exerting the greatest influence. Understanding the mechanisms underlying the protective function(s) of complement remains an important challenge for the future and has implications for the use of complement therapy in SLE. We review recent advances in the field and give a new perspective on the complement conundrum in SLE.
Asunto(s)
Activación de Complemento , Proteínas del Sistema Complemento , Lupus Eritematoso Sistémico , Lupus Eritematoso Sistémico/inmunología , Humanos , Animales , Activación de Complemento/inmunología , Proteínas del Sistema Complemento/inmunología , Proteínas del Sistema Complemento/metabolismo , Complemento C1q/inmunología , Complemento C1q/metabolismo , Ratones , Vía Clásica del Complemento/inmunologíaRESUMEN
The complement (C) system is implicated in the etiopathogenesis of rheumatoid arthritis (RA). However, there is a lack of studies characterizing all three C pathways in RA patients. This study aimed to evaluate the association between an in-depth examination of the C system and RA patient characteristics, focusing on disease activity and the presence of rheumatoid factor and anti-citrullinated protein autoantibodies (ACPA). In a cohort of 430 RA patients, functional assays of the three C pathways (classical, alternative, and lectin) and serum levels of their components were assessed. Components included C1q (classical); factor D and properdin (alternative); lectin (lectin); C1-inhibitor; C2, C4, and C4b (classical and lectin); C3, C3a, and C4b (common); and C5, C5a, and C9 (terminal). A multivariable linear regression analysis showed significant positive correlations between C-reactive protein and C system proteins and functional assays, especially in the terminal and common pathways. Disease activity, measured by scores with or without acute phase reactants, positively correlated with the classical pathway functional test and terminal pathway products. Conversely, rheumatoid factor or ACPA presence was associated with lower classical pathway values and decreased C3a and C4b levels, suggesting complement depletion. In conclusion, RA disease activity increases C molecules and functional complement assays, while rheumatoid factor or ACPA positivity is linked to C consumption. Our study offers a detailed analysis of the complement system's role in RA, potentially guiding the development of more targeted and effective treatment strategies.
Asunto(s)
Artritis Reumatoide , Factor Reumatoide , Humanos , Artritis Reumatoide/sangre , Artritis Reumatoide/inmunología , Artritis Reumatoide/metabolismo , Masculino , Femenino , Persona de Mediana Edad , Anciano , Factor Reumatoide/sangre , Adulto , Proteínas del Sistema Complemento/metabolismo , Proteínas del Sistema Complemento/inmunología , Anticuerpos Antiproteína Citrulinada/sangre , Vía Alternativa del Complemento , Activación de Complemento , Proteína C-Reactiva/metabolismo , Proteína C-Reactiva/análisis , Vía Clásica del ComplementoRESUMEN
The classical pathway of the complement system is activated by the binding of C1q in the C1 complex to the target activator, including immune complexes. Factor H is regarded as the key downregulatory protein of the complement alternative pathway. However, both C1q and factor H bind to target surfaces via charge distribution patterns. For a few targets, C1q and factor H compete for binding to common or overlapping sites. Factor H, therefore, can effectively regulate the classical pathway activation through such targets, in addition to its previously characterized role in the alternative pathway. Both C1q and factor H are known to recognize foreign or altered-self materials, e.g., bacteria, viruses, and apoptotic/necrotic cells. Clots, formed by the coagulation system, are an example of altered self. Factor H is present abundantly in platelets and is a well-known substrate for FXIIIa. Here, we investigated whether clots activate the complement classical pathway and whether this is regulated by factor H. We show here that both C1q and factor H bind to the fibrin formed in microtiter plates and the fibrin clots formed under in vitro physiological conditions. Both C1q and factor H become covalently bound to fibrin clots, and this is mediated via FXIIIa. We also show that fibrin clots activate the classical pathway of complement, as demonstrated by C4 consumption and membrane attack complex detection assays. Thus, factor H downregulates the activation of the classical pathway induced by fibrin clots. These results elucidate the intricate molecular mechanisms through which the complement and coagulation pathways intersect and have regulatory consequences.
Asunto(s)
Coagulación Sanguínea , Complemento C1q , Factor H de Complemento , Vía Clásica del Complemento , Fibrina , Humanos , Factor H de Complemento/metabolismo , Factor H de Complemento/inmunología , Fibrina/metabolismo , Complemento C1q/metabolismo , Complemento C1q/inmunología , Vía Clásica del Complemento/inmunología , Unión Proteica , Activación de Complemento/inmunología , Plaquetas/inmunología , Plaquetas/metabolismoRESUMEN
Helminths produce calreticulin (CRT) to immunomodulate the host immune system as a survival strategy. However, the structure of helminth-derived CRT and the structural basis of the immune evasion process remains unclarified. Previous study found that the tissue-dwelling helminth Trichinella spiralis produces calreticulin (TsCRT), which binds C1q to inhibit activation of the complement classical pathway. Here, we used x-ray crystallography to resolve the structure of truncated TsCRT (TsCRTΔ), the first structure of helminth-derived CRT. TsCRTΔ was observed to share the same binding region on C1q with IgG based on the structure and molecular docking, which explains the inhibitory effect of TsCRT on C1q-IgG-initiated classical complement activation. Based on the key residues in TsCRTΔ involved in the binding activity to C1q, a 24 amino acid peptide called PTsCRT was constructed that displayed strong C1q-binding activity and inhibited C1q-IgG-initiated classical complement activation. This study is the first to elucidate the structural basis of the role of TsCRT in immune evasion, providing an approach to develop helminth-derived bifunctional peptides as vaccine target to prevent parasite infections or as a therapeutic agent to treat complement-related autoimmune diseases.
Asunto(s)
Calreticulina , Complemento C1q , Evasión Inmune , Trichinella spiralis , Trichinella spiralis/inmunología , Complemento C1q/inmunología , Complemento C1q/metabolismo , Complemento C1q/química , Animales , Calreticulina/inmunología , Calreticulina/química , Calreticulina/metabolismo , Cristalografía por Rayos X , Unión Proteica , Simulación del Acoplamiento Molecular , Proteínas del Helminto/inmunología , Proteínas del Helminto/química , Activación de Complemento/inmunología , Inmunoglobulina G/inmunología , Humanos , Antígenos Helmínticos/inmunología , Antígenos Helmínticos/química , Triquinelosis/inmunología , Triquinelosis/parasitología , Vía Clásica del Complemento/inmunología , Conformación ProteicaRESUMEN
El sistema inmune media numerosas patologías, por lo que es importante conocer su estructura y funcionamiento. Se clasifica en innato y adquirido. El sistema inmune innato brinda una temprana e inespecífica respuesta contra los microorganismos. El sistema inmune adquirido humoral y celular nos brinda una respuesta específica para diferentes moléculas, posee memoria frente a los antígenos y diversidad para reaccionar a una gran variedad de antígenos.
The immune system mediates numerous pathologies functions por functioning it is important to know its structure and functioning. The immune system is classified into innate and adaptive immunity. The innate immunity provides early and non-specific response against microbes. The adaptive humoral and cellular immunity gives specificy for distinct molecules and has memory to enhance response to antigen and diversity to responde to large variety of antigen
Asunto(s)
Humanos , Linfocitos T/fisiología , Sistema Inmunológico/fisiología , Fagocitosis , Inmunoglobulinas/ultraestructura , Interleucinas , Vía Clásica del Complemento , Células Asesinas Inducidas por Citocinas/fisiología , Inmunidad Adaptativa , Inmunidad Humoral , Inmunidad Innata , AnticuerposRESUMEN
Dentro de la respuesta inmune humoral se encuentran componentes que mantienen la homeostasis de los organismos a través del control de agentes patógenos por medio de la opsonización, quimiotaxis de células fagocíticas facilitando el proceso de eliminación de lo extraño o sin su acompañamiento, en el caso de la formación de poros en la membrana celular. A un grupo de este conjunto de componentes de origen molecular proteico se denominósistema del complemento, el cual posee tres vías de activación (Clásica, Alternativa y Lectinas), funciona comoanafilatoxinas, reguladores y receptores. La presente revisión tiene como objetivo discutir acerca de los diferentes componentes del sistema del complemento en la escala animal enfocándose principalmente en peces teleósteos y mamíferos, como organismos modelos en busca de elucidar sus diferencias, homologías y respuestas.
Within the humoral immune response can be found components that maintain an organisms homeostasis viacontrol of pathogenic agents using opsonization, chemotaxis of phagocytic cells which facilitates the processof elimination of foreign bodies, or in its absence, the formation of pores in the cellular membrane. One of these groups of components, of protein origin, is referred to as the complement system, which has 3 means of activation (Classic, Alternative, and Lectins) and functions as anaphylactic toxins, regulators and receptors. The aim of this review is to discuss the different components of the complement system in the animal kingdom, focusing principally on teleost fish and mammals, as model organisms in the search to elucidate their differences, homologies, and answers.
Dentro da resposta imune humoral encontram-se componentes que mantém a homeostase do organismo através docontrole de patógenos, por opsonização, quimiotaxia de células fagocíticas que facilita o processo de eliminaçãode corpos estranhos, ou na sua ausência, a formação de poros na membrana celular. Este conjunto de componentes moleculares de origem protéica são chamados de sistema complemento, que tem três vias de ativação (clássica, alternativa e lectinas), funciona como anafilatoxinas, reguladores e receptores. Esta revisão tem como objetivo discutir os vários componentes do sistema complemento na escala animal focando principalmente em peixes teleósteos e mamíferos como organismos modelos na busca de elucidar suas diferenças, homologias e respostas.
Asunto(s)
Animales , Activación de Complemento/inmunología , Peces/inmunología , Proteínas del Sistema Complemento/inmunología , Vía Alternativa del Complemento/inmunología , Vía Clásica del Complemento/inmunología , Interacciones Huésped-Patógeno/inmunología , Suero/inmunologíaRESUMEN
Las deficiencias congénitas de los componentes individuales de las vías clásica y alternativa del sistema del complemento, dan lugar a un conjunto de enfermedades de frecuencia relativamente baja. Las personas con deficiencias en estas funciones muestran una susceptibilidad elevada a las infecciones piógenas recurrentes por microorganismos que habitualmente son eliminados por fagocitosis y, en algunos casos, se asocian con enfermedades autoinmunes. Cuando las deficiencias del complemento comprometen la formación del complejo de ataque a la membrana, asociado con la lisis de las bacterias fuera de los fagocitos, los pacientes también tienen aumentado el riesgo de infectarse con Neisseria . Se describen las características clínicas y moleculares que caracterizan a los defectos presentes en los componentes de las vías de activación clásica y alternativa del sistema del complemento
Asunto(s)
Vía Alternativa del Complemento , Vía Clásica del Complemento , Síndromes de InmunodeficienciaRESUMEN
Objetivos: Os objetivos deste estudo foram: avaliar a frequência de imunodeficiências primárias de anticorpos e Complemento em pacientes com lupus eritematoso sistêmico juvenil (LESJ); avaliar possíveis associações entre a presença de imunodeficiência primária (IDP) e dados demográficos, ocorrência de infecções, manifestações clínicas, atividade da doença, dano cumulativo e terapêutica direcionada ao LESJ; e determinar a frequência do anticorpo anti-C1q, estabelecendo a sua especificidade, sensibilidade e valores preditivos para o diagnóstico de LESJ. Métodos: Setenta e dois pacientes com LESJ foram avaliados para a determinação dos níveis séricos de imunoglobulinas (IgG, IgA, IgM e IgE) e subclasses de IgG, e dos componentes iniciais da via clássica do sistema Complemento (C1q, C1r, C1s, C4, C2, C3). Sessenta e sete pacientes e 26 controles saudáveis foram avaliados para a presença do anticorpo anti-C1q. O número de cópias do gene C4 foi determinado por PCR (reação de polimerase em cadeia) em tempo real nos pacientes com deficiência de C4. Setenta pacientes foram avaliados para a presença de deficiência de C2 tipo I. Resultados: Evidência de IDP foi identificada em 16 pacientes (22%): 3 com deficiência (D) de C2, 3 com C4D, 2 com C1qD, 4 com IgG2D (<20mg/dL), 3 com IgAD (<7mg/dL), e 3 com IgMD (<35mg/dL); um destes pacientes apresentou deficiência concomitante de IgA, C4 e C2. Quatro dos 13 pacientes do sexo masculino (30%) e 12 das 59 pacientes do sexo feminino (20%) apresentaram diagnóstico de IDP. As características clínicas de LES não diferiram entre os pacientes com e sem IDP. A mediana do SLICC/ACR-DI foi maior entre os pacientes com IDP (p=0,0033), assim como a frequência de SLICC/ACR-DI>1 (p=0,023). Os grupos também foram semelhantes quanto à ocorrência de infecção e terapêutica utilizada para o LESJ. Os únicos dois casos de LESJ com idade de início antes dos 2 anos apresentaram C1qD e IgMD, respectivamente. Para o diagnóstico de LESJ...
Objectives. The objectives of this study were: to establish the frequency of primary immunoglobulin and Complement deficiency in Juvenile SLE (JSLE); to evaluate possible associations between the presence of primary immunodeficiency and demographic data, occurrence of infections, JSLE clinical manifestations, disease activity, cumulative damage and therapy; and to determine the frequency of anti-C1q antibody, establishing its sensitivity, specificity and predictive values for JSLE diagnosis. Methods. Seventy-two JSLE patients were analyzed for serum levels of immunoglobulin classes (IgG, IgA, IgM e IgE) and IgG subclasses and early components of the classical Complement pathway (C1q, C1r, C1s, C4, C2, C3). Sixty-seven patients and 26 healthy controls were evaluated for the presence of anti-C1q antibody. C4 gene copy number was determined by real time PCR (polymerase chain reaction) in C4 deficient patients. Seventy patients were analyzed by PCR for the presence of type I C2 deficiency. Results. Evidence of PID was identified in 16 patients (22%): 3 with C2 deficiency (D), 3 with C4D, 2 with C1qD, 4 with IgG2D (<20mg/dL), 3 with IgAD (<7mg/dL), and 3 with IgMD (<35mg/dL); one of these patients presented concomitant IgA, C2 and C4 deficiency. Four out of the 13 boys (30%) and 12 out of 59 girls (20%) had PID diagnosis. SLE features did not differ between patients with and without PID. The median SLICC/ACR-DI was higher among PID subjects (p=0.0033), as was the frequency of SLICC/ACR-DI>1 (p=0.023). Both groups did not differ regarding the occurrence of infections and therapeutic for JSLE. The only 2 cases with age of onset below 2 years presented C1qD and IgMD, respectively. For JSLE diagnosis, the anti-C1q antibodies presented a specificity of 100% (CI 86.7-100%), sensitivity of 19.4% (CI 10.7-30.8%), positive predictive value of 100% (CI 75.3-100%) and negative predictive value of 32,5% (CI 22,4-43,9%). Conclusions. A high frequency of immunoglobulin...
Asunto(s)
Humanos , Masculino , Femenino , Niño , Anticuerpos Antinucleares , Complemento C1q , Vía Clásica del Complemento , Inmunoglobulinas , Síndromes de Inmunodeficiencia , Lupus Eritematoso SistémicoRESUMEN
A rejeição ao aloenxerto mediada por mecanismos celulares ou humorais representa uma importante complicação no pós-transplante renal. Estudos anteriores demonstraram que o depósito de C4d peritubular é um marcador de rejeição mediada por anticorpos. A técnica padrão ouro para a pesquisa de C4d é a imunofluorescência em criostato. No entanto, o manuseio do material congelado implica em algumas limitações custo-operacionais, particularmente em nosso meio. Nos casos de rejeição mediada por anticorpos é de relevância patogenética a análise da participação de linfócitos B e plasmócitos, pois são as células responsáveis pela produção de anticorpos. Considerando que até o momento o envolvimento de linfócitos B e plasmócitos no processo de rejeição foi pouco investigado, no presente estudo também será analisada a expressão de CD20 e CD138 em biópsias renais, para caracterização destes componentes celulares. Portanto, o objetivo do presente estudo foi analisar a detecção do fragmento C4d por meio de 4 diferentes técnicas, além de analisar o infiltrado de linfócitos B e plasmócitos em biópsias de enxerto renal, correlacionando estes achados com o C4d peritubular. Foram analisadas 107 biópsias de 82 pacientes submetidos a transplante renal. A pesquisa do C4d foi realizada utilizando-se as técnicas de imunofluorescência [IF] (em cortes de criostato e de parafina) e imuno-histoquímica [IH] (em cortes de criostato e de parafina), enquanto que as pesquisas dos linfócitos B e plasmócitos foram realizadas pela técnica de IH em cortes de parafina utilizando-se os anticorpos anti-CD20 e anti-CD138, específicos para linfócitos B e plasmócitos, respectivamente. Com relação à detecção de C4d, as técnicas com maior índice de concordância com a IF-criostato, considerada padrão-ouro, foram IH-criostato (75,6% dos casos apresentaram resultados coincidentes, r=0,72; p<0,0001) e IF-parafina (73%, r=0,59; p=0,0001), enquanto a taxa de concordância na técnica de IH-parafina...
Allograft rejection mediated by cellular or humoral mechanisms represents an important complication after kidney transplantation. Capillary C4d deposition was recognized as a specific and independent prognostic marker of antibody mediated rejection. The gold standard technique for C4d detection is the immunofluorescence in cryostat sections. However, this technique involves some operating and costs limitations, particularly in Brazil. In antibody mediated rejection, the analysis of B lymphocytes and plasma cells is of pathogenetic relevance since these cells are responsible for antibody production. Considering that the involvement of B lymphocytes and plasma cells in the rejection process is not clear, in this study the CD20 and CD138 expression in kidney biopsies will be also analyzed. Therefore, the aim of the present study was to analyze the C4d detection by 4 different techniques and the infiltration of B lymphocytes and plasma cells in renal allograft biopsies, correlating these findings with the capillary C4d deposition. One hundred and seven biopsies of 82 renal transplant patients were analyzed. C4d was evaluated by immunofluorescence (IF) and immunohistochemistry (IHC) techniques in frozen and paraffin sections (obtained from the same patients), whereas B-lymphocytes and plasma cells were evaluated by immunohistochemistry in paraffin sections using specific antibodies anti-B Lymphocytes (CD20) and anti-plasma cells (CD138). Regarding the C4d detection, the techniques with higher concordance rate with frozen-IF, considered the gold standard, were the frozen-IHC technique (85.4% of cases showed coincident results, r=0.72; p<0.0001) and the paraffin-IF technique (73%, r=0.59; p=0.0001), where as the concordance rate in the paraffin-IHC technique was only 51.4% (r=0.35; p=0.03). The clinical follow up analysis demonstrate that C4d positive group was associated with a poor graft survival at 3 years post-diagnosis (67% vs 96% in C4d negative group; p=0.01)...
Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Persona de Mediana Edad , Linfocitos B , Vía Clásica del Complemento , Técnica del Anticuerpo Fluorescente , Rechazo de Injerto , Inmunohistoquímica , Trasplante de Riñón , Células Plasmáticas , Trasplante HomólogoRESUMEN
OBJETIVO: Avaliar a atividade funcional das vias clássica e alternativa do sistema complemento e os níveis de C3, C4 e fator B durante o primeiro episódio de infecção meningocócica e durante a convalescença. PACIENTES E MÉTODOS: Dez crianças brasileiras com idades entre 8 meses e 8 anos, admitidas de 1991 a 1993, com diagnóstico clínico-laboratorial de meningite meningocócica, foram estudadas durante infecção aguda (até 7 dias do diagnóstico) e no período de convalescença (entre 1 e 6 meses após). C3, C4 e fator B foram quantificados por nefelometria e a atividade lítica das vias clássica e alternativa foi avaliada por método cinético e expressa como tempo necessário para lisar 50% de uma suspensão de eritrócitos (T1/2, expresso em segundos). Baixos valores de T1/2 das vias clássica e alternativa se correlacionam com elevadas atividades de via clássica e via alternativa, respectivamente. RESULTADOS: Observaram-se diferenças significativas entre a atividade lítica da via alternativa durante a infecção e no período de convalescença (282 e 238 segundos, respectivamente, P= .01). Nenhuma diferença foi detectada nos outros parâmetros analisados. CONCLUSÕES: Na presença de meningite meningocócica a via alternativa é preferencialmente ativada, provavelmente devido à maior capacidade da endotoxina meningocócica para ativar esta via, in vivo.
Asunto(s)
Humanos , Lactante , Preescolar , Niño , Complemento C3 , Complemento C4 , Factor B del Complemento/análisis , Vía Alternativa del Complemento/inmunología , Vía Clásica del Complemento/inmunología , Meningitis Meningocócica/inmunología , Enfermedad Aguda , Brasil , Ensayo de Actividad Hemolítica de Complemento , Convalecencia , Meningitis Meningocócica/sangre , Nefelometría y Turbidimetría , Valores de ReferenciaRESUMEN
Se estudiaron los fenómenos de solubilización e inhibición de la precipitación de inmunocomplejos en un grupo de 39 pacientes con anemia drepanocítica en crisis hepática (13) y en estado basal (26), utilizando como modelo el complejo125 I-toxoide tetánico/anti-toxoide tetánico. La inhibición de la precipitación estuvo disminuida en la crisis hepática y en el estado basal, con valores normales de la actividad hemolítica de la vía clásica y de los niveles séricos del C4, mientras que la disminución de la solubilización en la crisis hepática estuvo relacionada con una disminución de la actividad hemolítica de la vía alternativa, la actividad hemolítica del factor B y los niveles del componente C3, y con un aumento de los inmunocomplejos circulantes. Nuestros resultados sugieren la posible utilidad de estos mecanismos para evaluar otras funciones del complemento, no detectadas mediante una determinación de la actividad hemolítica, como medida de la función de las vías clásica y alternativa.
Asunto(s)
Humanos , Anemia de Células Falciformes , Complejo Antígeno-Anticuerpo , Vía Alternativa del Complemento , Vía Clásica del ComplementoRESUMEN
Se obtuvo un preparado concentrado del componente C1 (q, r, s) del sistema completo en forma inactiva por un método de precipitación, libre de contaminación con los restantes componentes iniciales de la vía clásica, el C2 y el C4. Este preparado se mantuvo estable a 2 °C y en los ensayos funcionales fue capaz de fijarse al complejo EAC4, activar los componentes C2 y C4 para formar la convertasa del C3, y provocar la lisis de estas células. La reacción de hemólisis fue activada por el C2 e inhibida por el Cl inhibidor, lo que indica la especificidad del C1 obtenido.Este pudiera emplearse para lograr un antisuero específico, para la obtención de los subcomponentes C1q, C1r y C1s, o para la estandarización de métodos funcionales de estudiar el C1, el C2 o el C1 inhibidor.
Asunto(s)
Complemento C1q , Complemento C1r , Complemento C1s , Complemento C4 , Vía Clásica del ComplementoRESUMEN
Se describe un método de purificación del componente C1q del sistema del complemento a partir de la fracción I de Cohn, mediante cromatografía de intercambio iónico, empleando una resina Bio-Rex 70 y un gradiente de fosfato de sodio 50 mM, pH 7,3 + 2 mM EDTA + NaCL 82 mM-300 mM. Se detectó la presencia de C1q en las fracciones eluídas y las seleccionadas se precipitaron con sulfato de amonio saturado al 33 porciento. Mediante inmunodifusión doble e inmunoelectroforesis contra un suero antiproteínas séricas humanas y un antisuero específico, se determinó la pureza del C1q obtenido
Asunto(s)
Complemento C1q/aislamiento & purificación , Vía Clásica del Complemento , Cromatografía por Intercambio Iónico/métodosRESUMEN
Se determinó la actividad hemolítica de las vías clásica, alternativa, del factor B, del factor D, así como los niveles de C1q, C3 y C4, en el suero de 24 pacientes adultos con enfermedad de Hodgkin en diferentes estadios clínicos. Se detectó una disminución significativa (p < 0,001) de las vías clásica, alternativa, factor B y la concentración de C3 y C4 en los estadios más avanzados de la enfermedad, IIIB y IVB. Los datos obtenidos en nuestro trabajo sugieren una posible asociación entre las alteraciones del sistema complemento con la extensión de la enfermedad.
Asunto(s)
Humanos , Masculino , Adolescente , Adulto , Persona de Mediana Edad , Femenino , Complemento C1q , Complemento C3 , Complemento C4 , Vía Alternativa del Complemento , Vía Clásica del Complemento , Enfermedad de HodgkinRESUMEN
Se determinó la frecuencia de 29 antígenos HLA de los loci A y B en 20 pacientes con glaucoma primario de ángulo abierto diagnósticados en el Servicio de Oftalmología del Hospital General Docente ®Enrique Cabrera¼. Se utilizaron como controles 276 personas sanas. El antígeno HLA B35 mostró asociación positiva con un riesgo relativo (RR) de 5,3. Se obtuvo una frecuencia estadísticamente significativa con una p corregida (pc) <0,002 para el HLA B35 al compararla con controles normales no relacionados. El resto de los antígenos HLA estudiados no mostraron asociación
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Complejo Antígeno-Anticuerpo , Complemento C3 , Complemento C4 , Factor B del Complemento , Vía Alternativa del Complemento , Vía Clásica del Complemento , Mieloma Múltiple/inmunologíaRESUMEN
Se efectuó la determinación de la actividad hemolítica de la vía clásica y la cuantificación de los componentes C3 y C4 del sistema del complemento en 48 mujeres con embarazos a término, 20 con antecedentes de abortos espontáneos y 28 normales, así como la determinación de inmunocomplejos circulantes y los niveles séricos de IgG, IgA e IgM. Se demostró una disminución significativa (p < 0,001) de la actividad de la vía clásica y de C3 en el grupo de mujeres abortadoras al compararlas con las normales. No se observaron alteraciones en el resto de los parámetros estudiados. Estos datos sugieren la posible participación del sistema del complemento en el mecanismo del aborto espontáneo
Asunto(s)
Humanos , Femenino , Embarazo , Adulto , Complejo Antígeno-Anticuerpo/sangre , Complemento C3/análisis , Complemento C4/análisis , Inmunoglobulina A/sangre , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Vía Clásica del Complemento/inmunologíaRESUMEN
Se exploraron las propiedades moduladoras de seis plantas nativas de Guatemala sobre las vías clásica y alterna del sistema de complemento. Para ello se evaluaron siete extractos etanólicos de diferentes órganos de las plantas seleccionadas: la hierba de Cissampelos tropaeolifolia, la hoja de Justicia pectoralis, la hoja de Lippia chiapasensis, la hoja de Pimenta dioica, la hoja de Piper auritum, y la flor y hoja de Ternstroemia tepezapote; mediante la aplicación de una modificación de los ensayos hemolíticos descritos por Klerx et.al., estandarizada en el laboratorio del Departamento de Citohistología de la Facultad de Ciencias Químicas y Farmacia USAC. Los extractos etanólicos de la hoja de Ternstroemia tepezapote (CI50=3.02 µg/ml) y la hoja de Lippia chiapasensis (CI50=13.99 µg/ml) mostraron actividad inhibitoria de la vía clásica del sistema de complemento. El extracto etanólico de Lippia chiapasensis (CI50=14.45 µg/ml) mostró actividad inhibitoria de la vía alterna del sistema de complemento. Los extractos etanólicos de la hoja de Pimenta dioica, la hoja de Piper auritum, la flor de Ternstroemia tepezapote, la hoja de Justicia pectoralis y la hierba de Cissampelos tropaeolifolia no presentaron actividad sobre ninguna de las dos vías del sistema de complemento. Con base en los resultados obtenidos, fue comprobada la hipótesis de que el extracto etanólico de al menos una de las seis plantas nativas de Guatemala evaluadas, posee acción inmunomoduladora sobre el sistema de complemento. Se sugiere realizar investigaciones para determinar los principios activos presentes en los extractos que proveen la actividad moduladora, apoyando la posible aplicación de estos en el manejo y tratamiento de enfermedades autoinmunes e inflamatorias